The Vietnam vaccine market was valued at USD 3.93 Billion in 2025, driven by the advancements in vaccine technology and robust government initiatives in the region. The market is anticipated to grow at a CAGR of 9.60% during the forecast period of 2026-2035, with the values likely to reach USD 9.83 Billion by 2035.
Base Year
Historical Period
Forecast Period
The increasing prevalence of infectious diseases, including dengue, influenza, hepatitis, HPV, and Rotavirus, is expected to fuel the market demand in Vietnam.
The shift toward prioritizing vaccination as a key strategy to reduce child mortality and hospitalizations is projected to elevate the Vietnam vaccine market value in the forecast period.
The robust regulatory support for new vaccines, such as Takeda’s dengue vaccine, is a significant market trend.
Compound Annual Growth Rate
9.6%
Value in USD Billion
2026-2035
*this image is indicative*
The vaccine market in Vietnam is experiencing significant growth driven by the rising demand for immunization against infectious diseases. With a rapidly growing population and increasing public awareness about the importance of vaccination, the market is projected to expand steadily in the coming years. Moreover, global pharmaceutical companies like Pfizer, Sanofi, GlaxoSmithKline, and Merck are significantly contributing to the market by providing a wide range of vaccines and investing in local manufacturing.
Rising Infectious Disease Incidence to Boost Market Growth
The rising incidence of infectious diseases like dengue, influenza, hepatitis, HPV, and Rotavirus is a key factor driving the vaccine market in Vietnam. In 2023, the WHO reported over 500,000 dengue cases and 750 deaths across the Western Pacific Region, including Vietnam. As of October 3, 2024, Vietnam had confirmed 76,838 cases of dengue and 12 deaths in that year. With the increasing disease burden and a growing focus on expanding vaccination coverage, the demand for vaccines in Vietnam is expected to rise significantly in the coming years.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Type
Market Breakup by Route of Administration
Market Breakup by Disease Indication
Market Breakup by Age
Market Breakup by End User
Segmentation Based on Product Type to Witness Substantial Growth
Based on the product type, the market is segmented into multivalent and monovalent vaccines. The multivalent vaccine segment holds a substantial market share due to its broad coverage against multiple strains or types of diseases in a single dose. These vaccines are usually favored for large-scale immunization programs, such as those for diphtheria, tetanus, pertussis, and HPV. Additionally, multivalent vaccines are cost-effective and more efficient, especially in countries like Vietnam, where there is a focus on reaching large populations with limited resources.
In Vietnam, the market dynamics vary significantly across different regions, influenced by factors like population density, healthcare infrastructure, and disease prevalence. Hanoi (northern Vietnam) has well-established medical facilities and a high level of awareness about vaccinations. The region benefits from government initiatives and also reports a higher adoption of newer vaccines. Ho Chi Minh City (southern Vietnam) also holds a high market value as it serves as a critical hub for vaccine research and development, attracting multinational pharmaceutical companies.
The key features of the market report comprise patent analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
GlaxoSmithKline (GSK) is a global healthcare company specializing in vaccines, medicines, and consumer health products. In Vietnam, GSK has made substantial contributions through investments in healthcare infrastructure, such as building a state-of-the-art warehouse for better vaccine storage and distribution. The company also focuses on bringing innovative vaccines to the country, thereby significantly contributing to the Vietnam vaccine market growth.
Merck & Co. is a leading healthcare company, particularly known for its vaccines and therapies in oncology, infectious diseases, and more. Merck offers vaccines for diseases like HPV, hepatitis, and influenza in Vietnam. The company works closely with local health authorities to promote disease prevention and vaccination efforts.
Sanofi, a multinational pharmaceutical company, focuses on the research and development of vaccines, medicines, and therapies for various health conditions. Sanofi is a key player in the Vietnam vaccine market, partnering with local entities like VNVC to produce vaccines domestically. The company provides a wide range of vaccines for preventable diseases, and its initiatives aim to improve accessibility and reduce vaccine costs across the country.
Pfizer Inc. is a global biopharmaceutical company, offering a wide range of innovative medicines and vaccines. In Vietnam, Pfizer is widely known for supplying millions of vaccine doses during the COVID-19 pandemic in partnership with BioNTech. Beyond COVID-19, Pfizer continues to collaborate with local partners like Vietnam Vaccine Joint Stock Company (VNVC) to improve public health, raise awareness, and ensure a steady vaccine supply.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include AstraZeneca plc and Johnson & Johnson Services, Inc.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by Disease Indication |
|
| Breakup by Age |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share